B. Riley Issues Pessimistic Forecast for MacroGenics (NASDAQ:MGNX) Stock Price
MacroGenics (NASDAQ:MGNX – Get Free Report) had its target price reduced by analysts at B. Riley from $5.00 to $3.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the biopharmaceutical company’s stock. B. Riley’s target price would suggest a potential upside of 101.34% from the stock’s previous […]
MacroGenics (NASDAQ:MGNX – Get Free Report) had its target price reduced by analysts at B. Riley from $5.00 to $3.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the biopharmaceutical company’s stock. B. Riley’s target price would suggest a potential upside of 101.34% from the stock’s previous […]
